Clinical trial

A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD

NCT02038829

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-01-01

PhasePHASE2

Study timeline

Study start (unknown)2014-01-01Date precision: month

Registry last updated2018-04-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

COPDunresolved

Interventions

SUN101 3 mcgDRUG

SUN-101 6.25 mcgDRUG

SUN-101 12.5 mcgDRUG

SUN-101 50 mcgDRUG

AclidiniumDRUG · verified · RxNorm: aclidinium

Sponsors & collaborators

Sunovion Respiratory Development Inc.lead sponsor

Mapped research locations

GreenvilleSouth Carolina, United States2 SpartanburgSouth Carolina, United States2 CharlotteNorth Carolina, United States1 RaleighNorth Carolina, United States1 ClearwaterFlorida, United States1 MedfordOregon, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02038829 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.